Inhibition of polo-like kinase 4 (PLK4): a new therapeutic option for rhabdoid tumors and pediatric medulloblastoma

por Sredni, Simone Treiger, Bailey, Anders W., Suri, Amreena, Hashizume, Rintaro, He, Xingyao, Louis, Nundia, Gokirmak, Tufan, Piper, David R., Watterson, Daniel M., Tomita, Tadanori
Publicado 2017